Reviva Pharmaceuticals Holdings, Inc. (RVPH)
0.7709
-0.07
(-8.77%)
USD |
NASDAQ |
Apr 10, 16:00
0.7863
+0.02
(+2.00%)
After-Hours: 20:00
Reviva Pharmaceuticals Holdings EPS Diluted (Quarterly) : -0.5734 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AbbVie, Inc. | 1.018 |
| Bristol Myers Squibb Co. | 0.5326 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.368M |
| Total Expenses (Quarterly) | 3.368M |
| Enterprise Value | -4.156M |
| Earnings Yield | -875.7% |
| Normalized Earnings Yield | -878.38 |